Licensed Product Development Clause Samples
Licensed Product Development. 4.2.1 Prior to the NDA Response Date, the Council in reasonable consultation with LICENSEE will use Commercially Reasonable Efforts to undertake the development and regulatory approval efforts toward obtaining a first approval of the NDA for the Licensed Product in the United States, at Council’s cost and expense.
Licensed Product Development. 4.3.1 Lian shall: (a) notify Tarsus prior to preparing the first draft of any protocol for a Clinical Trial involving a Licensed Product; (b) provide Tarsus with copies of each proposed protocol for such Clinical Trial; and (c) consider Tarsus’s comments with respect to such Clinical Trial.
4.3.2 Without the approval of the JSC, Lian shall not undertake any Development efforts (including conducting any preclinical studies or Clinical Trials) that are inconsistent with the then-current Development Plan, as approved by the JSC, for any Licensed Product.
Licensed Product Development. 8.1 Cosmederm shall be responsible for [ * ] of all research, development, manufacturing and marketing claims support costs of the Licensed Products specified in Exhibit A. Collagen is responsible for [ * ] of all other marketing, sales and distribution costs for the Licensed Products specified in Exhibit A, including, but not limited to, consumer acceptance studies, focus groups, and test market studies. The parties may mutually agree upon the allocation of costs related to the joint development of any additional Licensed Product(s) proposed by either Collagen or Cosmederm pursuant to Sections 7.1 and 7.2.
Licensed Product Development. Discovery shall be solely responsible for the development of Licensed Products and Chrysalis shall have no obligations with respect to the development of Licensed Products unless Chrysalis agrees otherwise in writing. Chrysalis acknowledges and agrees that Discovery may partner with third parties with respect to the development of Licensed Products.
Licensed Product Development. Subject to Section 5.2 (Development Diligence) and Article 7 (Manufacturing and Technology Transfer), as between the Parties, on a Licensed Product-by-Licensed Product basis, from and after the applicable Option Exercise Date, AstraZeneca will have the sole right, at its sole expense, to Develop the applicable Licensed Product in the Field in the Territory.
Licensed Product Development. 3.1 Overview. CAMP4 will, at [***], lead and have sole control over and decision-making authority for all Development activities for the Licensed Products in the Field in the Territory.
Licensed Product Development. 34 ARTICLE 8 CONSIDERATION.......................................................37 ARTICLE 9
Licensed Product Development. As between the Parties, Alzheon shall be solely responsible, at its sole cost, for the development, manufacture, and commercialization of Licensed Product in the Field in the Territory, and Alzheon shall be responsible for preparing and filing all
Licensed Product Development